Clinical Trial Update: Uracil and Tegafur/Leucovorin (UFT/LV) Versus UFT/LV+ Polysaccharide-K (PSK) for Stage IIIa/IIIb Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing uracil-tegafur-leucovorin (UFT/LV) alone versus UFT/LV plus polysaccharide-K (PSK) for stage III colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Polysaccharide-K (PSK) (polysaccharide-K)
• UFT/LV (Uracil and tegafur with leucovorin)

Snippet

Sponsor: Iwate Medical University | Conditions: Colorectal Cancer | Phase 3 | Status: UNKNOWN